Title:
PPAR MODULATOR
Document Type and Number:
Japanese Patent JP2013060465
Kind Code:
A
Abstract:
To provide use of 2,4-diphenyl-1,3-dioxanes in the treatment of a disease or condition dependent on PPAR modulation, such as diabetes, cancer, inflammation, neurodegenerative disorders and infections.
There are described 1,3-dioxane derivatives and their use in the treatment of a disease or condition dependent on PPAR modulation, such as diabetes, cancer, inflammation, neurodegenerative disorders and infections. The invention also relates to uses of compounds as defined above, for the preparation of a medicament for the treatment of diseases or conditions which are responsive to modulation of PPAR-γ activity, in particular any of the PPAR-γ responsive diseases or conditions described herein below.
Inventors:
KRISTIANSEN KARSTEN
MAINKAR PRATHAMA S
MEYER JEAN-PHILIPPE
SANTANA SORENSEN ALEXANDRA
MAINKAR PRATHAMA S
MEYER JEAN-PHILIPPE
SANTANA SORENSEN ALEXANDRA
Application Number:
JP2012286467A
Publication Date:
April 04, 2013
Filing Date:
December 28, 2012
Export Citation:
Assignee:
EVOLVA SA
International Classes:
C07D319/06; A61K31/36; A61K31/438; A61K31/4433; A61K31/537; A61K45/00; A61P1/04; A61P3/04; A61P3/06; A61P3/10; A61P9/12; A61P17/00; A61P17/06; A61P19/02; A61P29/00; A61P31/18; A61P35/00; A61P43/00; C07D319/08; C07D405/04; C07D407/04; C07D407/06; C07D491/113
Attorney, Agent or Firm:
Hidesaku Yamamoto
Natsuki Morishita
Natsuki Morishita
Previous Patent: THERAPY PROCEDURE FOR DRUG DELIVERY FOR TRIGEMINAL PAIN
Next Patent: INHIBITOR OF BRUTON'S TYROSINE KINASE
Next Patent: INHIBITOR OF BRUTON'S TYROSINE KINASE